Drop seizures cut by cannabidiol


Play all audios:

Loading...

Access through your institution Buy or subscribe Cannabidiol treatment reduces seizure frequency in patients with Lennox–Gastaut syndrome, a new phase III, double-blind placebo-controlled


trial has confirmed. Investigators found that a low dose of cannabidiol cut seizure frequency by more than a third. The Lennox–Gastaut syndrome is a severe type of childhood epilepsy


characterized by abnormal EEG signs, cognitive impairment and disabling drop seizures that can result in serious injury. Although several treatments have been approved for the Lennox–Gastaut


syndrome, currently available agents fail to halt seizures in most patients. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your


institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $29.99 / 30 days cancel any time Learn more Subscribe to this journal


Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices


may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support


REFERENCES ORIGINAL ARTICLE * Devinsky, O. et al. Effect of cannabidiol on drop seizures in the Lennox–Gastaut syndrome. _N. Engl. J. Med._ https://doi.org/10.1056/NEJMoa1714631 (2018)


Article  PubMed  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Nature Reviews Neurology http://www.nature.com/nrneurol/ Charlotte Ridler Authors *


Charlotte Ridler View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Charlotte Ridler. RIGHTS AND PERMISSIONS Reprints


and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Ridler, C. Drop seizures cut by cannabidiol. _Nat Rev Neurol_ 14, 380–381 (2018). https://doi.org/10.1038/s41582-018-0022-y Download


citation * Published: 01 June 2018 * Issue Date: July 2018 * DOI: https://doi.org/10.1038/s41582-018-0022-y SHARE THIS ARTICLE Anyone you share the following link with will be able to read


this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative